Analytical aspects of thyroid antibodies estimation

Autoimmunity

Volumn 41, Issue 1, 2008, Pages 46-54

  Sinclair, David ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Thyroglobulin; Thyroid antibody; Thyroid peroxidase; TSH receptor

Indexed keywords

HLA ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; AUTOIMMUNE THYROIDITIS; CELL MEDIATED CYTOTOXICITY; DIAGNOSTIC ACCURACY; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC LINKAGE; HEMAGGLUTINATION TEST; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOGENESIS; NONHUMAN; PASSIVE HEMAGGLUTINATION; REVIEW; SENSITIVITY AND SPECIFICITY; THYROID FOLLICLE CELL;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; HEMAGGLUTINATION TESTS; HUMANS; IMMUNOASSAY; PEROXIDASE; RECEPTORS, THYROTROPIN; THYROGLOBULIN; THYROID DISEASES; THYROID GLAND;

EID: 38049061134     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701619466     Document Type: Review

References (71)

1. Hashimoto, H. (1912) Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir (Berl), 97, pp. 219-248.
2. Weetman, AP (1997) New aspects of thyroid immunity. Horm Res, 48, p. 51.
3. Tamai, H., Kasagi, K., Takaichi, Y., Takamatsu, J., Komaki, G. and Matsubayashi, S. (1989) Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: Clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab, 69, pp. 49-53.
4. Takasu, N., Yamada, T., Sato, A., Nakagawa, M., Komiya, I. and Nagasawa, Y. (1990) Graves' disease following hypothyroidism due to Hashimoto's disease: Studies of eight cases. Clin Endocrinol (Oxf), 33, pp. 687-698.
5. Kraiem, Z., Baron, E., Kahana, L., Sadeh, O. and Sheinfeld, M. (1992) Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf), 36, pp. 211-214.
6. Dunn, JT and Ray, SC (1978) Variations in the structure of thyroglobulins from normal and goitrous human thyroids. J Clin Endocrinol Metab, 47, pp. 861-869.
7. Okosieme, OE, Parkes, AB, Premawardhana, LD, Evans, C. and Lazarus, JH (2003) Thyroglobulin: Current aspects of its role in autoimmune thyroid disease and thyroid cancer. Minerva Med, 94, pp. 319-330.
8. McLachlan, SM and Rapoport, B. (2004) Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies?. Thyroid, 14, pp. 510-520.
9. Lisi, S., Marino, M., Pinchera, A., Mazzi, B., Cosmo, C Di, Sellari-Franceschini, S. and Chiovato, L. (2002) Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: Predominant localization in fibroadipose tissue. Thyroid, 12, pp. 351-360.
10. Rapoport, B., Chazenbalk, GD, Jaume, JC and McLachlan, SM (1998) The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr Rev, 19, pp. 673-716.
11. Tahara, K., Ishikawa, N., Yamamoto, K., Hirai, A., Ito, K. and Tamura, Y. (1997) Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid, 7, pp. 867-877.
12. Chazenbalk, GD, Latrofa, F., McLachlan, SM and Rapoport, B. (2004) Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N-terminus of the thyrotropin receptor A-subunit. J Clin Endocrinol Metab, 89, pp. 1788-1793.
13. Minich, WB, Lenzner, C. and Morgenthaler, NG (2004) Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin Exp Immunol, 136, pp. 129-136.
14. McLachlan, SM and Rapoport, B. (1992) The molecular biology of thyroid peroxidase: Cloning, expression, and role as autoantigen in autoimmune thyroid disease. Endocr Rev, 13, pp. 192-206.
15. Portmann, L., Hamada, N., Heinrich, G. and DeGroot, LJ (1985) Antithyroid peroxidase antibody in patients with autoimmune thyroid disease: Possible identity with antimicrosomal antibody. J Clin Endocrinol Metab, 61, p. 10013.
16. Czarnocka, B., Ruf, J., Ferrand, M., Carayon, P. and Lissitzky, S. (1985) Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett, 190, p. 14752.
17. Rapoport, B. and McLachlan, SM (2001) Thyroid autoimmunity. J Clin Invest, 108, pp. 1253-1259.
18. Khoury, EL, Hammond, L., Bottazzo, GF and Doniach, D. (1981) Presence of the organspecific "microsomal" autoantigen on the surface of human thyroid cells in culture: Its involvement in complementmediated cytotoxicity. Clin Exp Immunol, 45, pp. 316-328.
19. Jaume, JC, Guo, J., Pauls, DL, Zakarija, M., McKenzie, JM and Egeland, JA (1999) Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic "fingerprints". J Clin Endocrinol Metab., 84, pp. 1424-1431.
20. - symporter in the sera of patients with autoimmune thyroid disease. Biochem Biophys Res Comm, 224, pp. 92-95.
21. Heufelder, AE, Joba, W. and Morgenthaler, NG (2001) Autoimmunity involving the human sodium/iodide symporter: Fact or fiction?. Exp Clin Endocrinol Diab, 109, pp. 35-40.
22. Seissler, J., Wagner, S., Schott, M., Lettmann, M., Feldkamp, J. and Scherbaum, WA (2000) Low frequency of autoantibodies to the human Na(+)/ I(-) symporter in patients with autoimmune thyroid disease. J Clin Endocrinol Metab, 85, pp. 4630-4634.
23. Katakura, M., Yamada, T., Aizawa, T., Hiramatsu, K., Yukimura, Y. and Ishihara, M. (1987) Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. J Clin Endocrinol Metab, 64, p. 4058.
24. Marino, M., Chiovato, L., Friedlander, JA, Latrofa, F., Pinchera, A. and McCluskey, RT (1999) Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis. J Clin Endocrinol Metab, 84, pp. 2468-2474.
25. Weetman, AP (2003) Autoimmune thyroid disease: Propagation and progression. Eur J Endocrinol, 148, pp. 1-9.
26. Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P. and Papoff, G. (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science, 275, pp. 960-963.
27. Arscott, PL and Baker Jr, JR (1998) Apoptosis and thyroiditis. Clin Immunol Immunopathol, 87, pp. 207-217.
28. Czarnocka, B., Ruf, J. and Ferrand, M. (1985) Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett, 190, pp. 147-152.
29. Hollowell, JG, Staehling, NW, Hannon, WH, Flanders, WD, Gunter, EW and Spencer, CA (2002) Serum thyrotropin, thyroxine and thyroid antibodies in the United States population (1988 to 1994): NHANES III. J Clin Endocrinol Metab, 87, pp. 489-499.
30. Zophel, K., Saller, B., Wunderlich, G., Gruning, T., Koch, R. and Wilde, J. (2003) Autoantibodies to thyroperoxidase (TPO antibody) in a large population of euthyroid subjects: Implications for the definition of TPO antibody reference intervals. Clin Lab, 49, pp. 591-600.
31. Feldt-Rasmussen (1991) Anti-thyroid peroxidase antibodies in thyroid disorders and non thyroid autoimmune diseases. Autoimmunity, 9, pp. 245-251.
32. Vanderpump, MPJ, Tunbridge, WMG, French, JM, Appleton, D., Bates, D. and Rodgers, H. (1995) The incidence of thyroid disorders in the community; a twenty year follow up of the Whickham survey. Clin Endocrinol, 43, pp. 55-68.
33. Estienne, V., Duthoit, C., Costanzo, VD, Lejeune, PJ, Rotondi, M. and Kornfeld, S. (1999) Multicenter study on TGPO autoantibodies prevalence in various thyroid and non-thyroid diseases: Relationships with thyroglobulin and thyroperoxidase autoantibody parameters. Eur J Endocrinol, 141, pp. 563-569.
34. Chiovato, L., Latrofa, F., Braverman, LE, Pacini, F., Capezzone, M. and Masserini, L. (2003) Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med, 139, pp. 346-351.
35. Baloch, Z., Carayon, P., Conte-Devolx, B., Demers, LM, Feldt-Rasmussen, U. and Henry, JF (2003) Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 13, pp. 3-126.
36. Demers, LM and Spencer, CA (2003) Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol, 58, pp. 138-140.
37. Spencer, CA, Takeuchi, M., Kazarosyan, M., Wang, CC, Guttler, RB and Singer, PA (1998) Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab, 83, pp. 1121-1127.
38. Ruf, J., Carayon, P. and Lissitzky, S. (1985) Various expression of a unique anti-human thyroglobulin antibody repertoire in normal state and autoimmune disease. Eur J Immunol, 15, pp. 268-272.
39. Feldt-Rasmussen, U. and Rasmussen, AK (1985) Serum thyroglobulin (TG) in the presence of thyroglobulin autoantibodies (TGAb). Clinical and methodological relevance of the interaction between TG and TGAb in vivo and in vitro. J Endocrinol Invest, 8, pp. 571-576.
40. Spencer, CA, Wang, C., Fatemi, S., Guttler, RB, Takeuchi, M. and Kazarosyan, M. (1998) Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab, 83, pp. 1121-1127.
41. Ericsson, UB, Christensen, SB and Thorell, JI (1985) A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol, 37, pp. 154-162.
42. Cerbo, A Di, Paoloa, R Di, Menzaghi, C., De Filippis, V., Tahara, K. and Corda, D. (1999) Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on the thyrotropin receptor. J Clin Endocrinol Metab, 84, pp. 3283-3292.
43. Kosugi, S., Ban, T., Akamizu, T., Valente, W. and Kohn, LD (1993) Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. J Clin Endocrinol Metab, 77, pp. 19-24.
44. Nagayama, Y. and Rapoport, B. (1992) Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: Selective role of receptor amino acids Ser25-Glu30. J Clin Endocrinol Metab, 75, pp. 1425-1430.
45. Ando, T., Latif, R., Daniel, S., Eguchi, K. and Davies, TF (2004) Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinol, 145, pp. 5185-5193.
46. Shimojo, N., Kohno, Y., Yamaguchi, K., Kikuoka, S., Hoshioka, A. and Niimi, H. (1996) Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA, 93, pp. 11074-11079.
47. Costagliola, S., Many, MC, Denef, JF, Pohlenz, J., Refetoff, S. and Vassart, G. (2000) Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest, 105, pp. 803-811.
48. Kita, M., Ahmad, L., Marians, RC, Vlase, H., Unger, P. and Graves, PN (1999) Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease. Endocrinology, 140, pp. 1392-1398.
49. Nagayama, Y., Kita-Furuyama, M., Ando, T., Nakao, K., Mizuguchi, H. and Hayakawa, T. (2002) A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol, 168, pp. 2789-2794.
50. Weetman, AP, Yateman, ME, Ealey, PA, Black, CM, Reimer, CB and Williams Jr, RC (1990) Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest, 86, pp. 723-727.
51. Southgate, K., Creagh, FM, Teece, M., Kingswood, C. and Smith, B Rees (1984) A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol, 20, pp. 539-543.
52. Shewring, G. and Rees-Smith, B. (1982) An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol, 17, pp. 409-417.
53. Feldt-Rasmussen, U. (1996) Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin and thyrotropin receptor. Clin Chem, 42, pp. 160-163.
54. Ueta, Y., Fukui, H., Murakami, M., Yamanouchi, Y., Yamamoto, R. and Murao, A. (1999) Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy. Thyroid, 9, pp. 179-182.
55. Gupta, MK (2000) Thyrotropin-receptor antibodies in thyroid diseases: Advances in detection techniques and clinical application. Clin Chem Acta, 293, pp. 1-29.
56. Kung, AWC, Lau, KS and Kohn, LD (2001) Epitope mapping of TSH receptor-blocking antibodies in Graves' disease that appear during pregnancy. J Clin Endocrinol Metab, 86, pp. 3647-3653.
57. Kung, AW, Lau, KS and Kohn, LD (2000) Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy. Thyroid, 10, pp. 909-917.
58. Filetti, S., Foti, D., Costante, G. and Rapoport, B. (1991) Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor antibodies. J Clin Endocrinol Metab, 72, pp. 1096-1101.
59. Adams, DD and Purves, HD (1956) Abnormal responses in the assay of thyrotropin. Proceedings of the University of Otago Medical School, 34, p. 11.
60. Adams, DD, Fastier, FN and Howie, JB (1974) Stimulation of the human thyroid by infusions of plasma containing LATS protector. J Clin Endocrinol Metab, 39, p. 826.
61. Fisher, DA (1986) Neonatal thyroid disease in the offspring of mothers with autoimmune thyroid disease. Thyroid Today, 9, p. 1.
62. Morgenthaler, NG (1998) New assay systems for thyrotropin receptor antibodies. Curr Opin Endocrinol Diabetes, 6, pp. 251-260.
63. Kamijo, K., Nagata, A. and Sato, Y. (1999) Clinical significance of a sensitive assay for thyroid-stimulating antibodies in Graves' disease using polyethylene glycol at high concentration and porcine thyroid cells. Endocrinol J, 46, pp. 397-403.
64. Takasu, N., Yamashiro, K., Ochi, Y., Sato, Y., Nagata, A. and Komiya, I. (2001) TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism. Horm Metab Res, 33, pp. 232-237.
65. Akamizu, T., Inoue, D., Kosugi, S., Kohn, LD and Mori, T. (1994) Further studies of amino acids (268-304) in thyrotropin (TSH)-lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: Cysteine-301 is important in TSH binding and receptor tertiary structure. Thyroid, 4, pp. 43-48.
66. Grasso, YZ, Kim, MR, Faiman, C., Kohn, LD, Tahara, K. and Gupta, MK (1999) Epitope heterogeneity of thyrotropin-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors. Thyroid, 9, pp. 521-537.
67. Kim, WB, Chung, HK, Lee, HK, Kohn, LD, Tahara, K. and Cho B.Y. (1997) Changes in epitopes for thyroid stimulation antibodies in Graves' disease sera during treatment of hyperthyroidism: Therapeutic implications. J Clin Endocrinol Metab, 82, pp. 1953-1959.
68. Shewring, G. and Smith, BR (1982) An improved radioreceptor assay for TSH receptor. Methods Enzymol, 17, pp. 409-417.
69. Costagliola, S., Morganthaler, NG, Hoermann, R., Badenhoop, K., Struck, J. and Freitag, D. (1999) Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab, 84, pp. 90-97.
70. Schott, M., Feldkamp, J., Bathan, C., Fritzen, R., Scherbaum, WA and Seissler, J. (2000) Detecting TSH-receptor antibodies with the recombinant TBII assay: Technical and clinical evaluation. Horm Metab Res, 32, pp. 429-435.
71. Giovanella, L., Ceriani, L. and Garancini, S. (2001) Clinical applications of the 2nd. generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st. generation test. Clin Chem Lab Med, 39, pp. 25-28.